1990
DOI: 10.1016/0952-3278(90)90057-r
|View full text |Cite
|
Sign up to set email alerts
|

Platelet-activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

1991
1991
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(6 citation statements)
references
References 118 publications
1
5
0
Order By: Relevance
“…4 These pathways include activation of a GTPase that inhibits adenylate cyclases; stimulation of Ca 2 + stores and activation of phospholipases that yield diacyglycerol, inositol triphosphate and free arachidonic acid which can be acted upon through the cyclooxygenase and lipoxygenase pathways to give eicosanoids. 42 It is interesting and consistent with the above PAF receptor interaction hypothesis that the authors previously reported an inhibition of adenylate cyclase, 43 increased intracellular level of calcium, 44 increased lung phospholipase A2 activity 4s and increased plasma 46 and lung 4 levels of some eicosanoid in a bleomycin hamster model of pulmonary fibrosis.…”
Section: Discussionsupporting
confidence: 77%
“…4 These pathways include activation of a GTPase that inhibits adenylate cyclases; stimulation of Ca 2 + stores and activation of phospholipases that yield diacyglycerol, inositol triphosphate and free arachidonic acid which can be acted upon through the cyclooxygenase and lipoxygenase pathways to give eicosanoids. 42 It is interesting and consistent with the above PAF receptor interaction hypothesis that the authors previously reported an inhibition of adenylate cyclase, 43 increased intracellular level of calcium, 44 increased lung phospholipase A2 activity 4s and increased plasma 46 and lung 4 levels of some eicosanoid in a bleomycin hamster model of pulmonary fibrosis.…”
Section: Discussionsupporting
confidence: 77%
“…Arachidonic acid (20:4n-6) released by PLA2 is used for synthesis of eicosanoids, such as PGE2 and LTB4 by cyclooxygenase (COX) or lipoxygenase (18). Several studies demonstrate that increased production of eicosanoids, especially LTB4, during inflammation or caused by endotoxin is dependent on PAF concentration (17,32).…”
Section: Discussionmentioning
confidence: 99%
“…PAF can stimulate platelet and leukocyte aggregation, promote oxygen free radical production, increase adhesion molecules, lead to white blood cell adhesion, and aggregate and increase oxygen radicals [45]. PAF can dilate blood vessels, increase vascular permeability, make plasma infiltration out, reduce the blood volume, cause extensive edema of the colonic mucosa [46], stimulate intestinal secretion induced diarrhea, and promote the release of prostaglandins and leukotrienes and other inflammatory reactions [47]. PAF and platelets activate each other, making active UC abnormal blood rheology and lead to thrombotic complications; PAF binds to surface receptors of target cell and activates nuclear factor NF- κ B, which upregulates the synthesis and secretion of TNF- α , IL-1 [48, 49].…”
Section: Discussionmentioning
confidence: 99%